BNR Burning Rock Biotech Limited
Burning Rock Biotech Limited (BNR) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: June 26, 2026 , by Han Yusheng .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Han Yusheng | Director | Buy | 24,900 | $8.00 | $199.1K | 18,404,086 | |
| Han Yusheng | Director | Buy | 250,000 | $8.00 | $2.0M | 18,379,186 | |
| Han Yusheng | Director | Buy | 5,990 | $7.50 | $44.9K | 18,129,186 | |
| Han Yusheng | Director | Buy | 104,650 | $7.45 | $779.7K | 18,123,196 | |
| Han Yusheng | Director | Buy | 111,110 | $9.00 | $1000.0K | 18,018,546 | |
| Han Yusheng | Director | Buy | 210,000 | $9.25 | $1.9M | 17,907,436 | |
| Han Yusheng | Director | Buy | 24,760 | $8.74 | $216.4K | 17,697,436 | |
| Han Yusheng | Director | Buy | 314,870 | $17.36 | $5.5M | 17,672,676 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.